Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
David S. H. Bell. (2016) Aspirin in the prevention of cardiovascular events in patients with diabetes. Postgraduate Medicine 128:2, pages 180-190.
Read now
Read now
Sana Khan, Saba Khan, Bibhu Prasad Panda, Mohd Akhtar & Abul Kalam Najmi. (2015) Potential effects of vildagliptin on biomarkers associated with prothrombosis in diabetes mellitus. Expert Opinion on Therapeutic Targets 19:12, pages 1607-1616.
Read now
Read now
Annika Lundström, Ann-Charlotte Laska, Magnus Von Arbin, Gun Jörneskog & Håkan Wallén. (2014) Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA. Platelets 25:2, pages 102-110.
Read now
Read now
Mario Malerba, Enrico Clini, Michele Malagola & Gian Carlo Avanzi. (2013) Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease. Expert Review of Hematology 6:4, pages 475-483.
Read now
Read now
Zsofia Patko, Albert Csaszar, Gyorgy Acsady, Karlheinz Peter & Meike Schwarz. (2012) Roles of Mac-1 and glycoprotein IIb/IIIa integrins in leukocyte–platelet aggregate formation: Stabilization by Mac-1 and inhibition by GpIIb/IIIa blockers. Platelets 23:5, pages 368-375.
Read now
Read now
Stephan Reinboldt, Folker Wenzel, Bernhard H. Rauch, Thomas Hohlfeld, Maria Grandoch, Jens W. Fischer & Artur-Aron Weber. (2009) Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets. Platelets 20:6, pages 441-444.
Read now
Read now
Articles from other publishers (61)
Flavia Urbano, Ilaria Farella, Giacomina Brunetti & Maria Felicia Faienza. (2023) Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy. International Journal of Molecular Sciences 24:15, pages 11980.
Crossref
Crossref
David J. Schneider. 2023. Diabetes and Cardiovascular Disease. Diabetes and Cardiovascular Disease
99
127
.
Julia S. Gauer, Ramzi A. Ajjan & Robert A. S. Ariëns. (2022) Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches. Journal of the American Heart Association 11:20.
Crossref
Crossref
Mélina Del Bianco-Rondeau, Maxime Robert-Halabi, Samara Bloom, Remi Rabasa-Lhoret, Jean-Claude Tardif, Marie Lordkipanidzé & Guillaume Marquis-Gravel. (2022) Aspirin for Primary Cardiovascular Prevention in Patients with Diabetes: Uncertainties and Opportunities. Thrombosis and Haemostasis 122:09, pages 1443-1453.
Crossref
Crossref
Rebecca C. Sagar, Ramzi A. Ajjan & Khalid M. Naseem. (2022) Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets. International Journal of Molecular Sciences 23:9, pages 4973.
Crossref
Crossref
Sanyam ShahDr.Dr. & Y.N. VermaDr.Dr.. (2022) CORRELATION OF HBA1C AND MEAN PLATELET VOLUME IN TYPE 2 DIABETIC PATIENTS: A CASE CONTROL STUDY. GLOBAL JOURNAL FOR RESEARCH ANALYSIS, pages 14-16.
Crossref
Crossref
Biying Wu, Ying Ye, Sisi Xie, Yintao Li, Xiaoting Sun, Mengyuan Lv, Ling Yang, Nan Cui, Qiying Chen, Lasse D. Jensen, Dongmei Cui, Guichun Huang, Ji Zuo, Shaochong Zhang, Wen Liu & Yunlong Yang. (2021) Megakaryocytes Mediate Hyperglycemia-Induced Tumor Metastasis. Cancer Research 81:21, pages 5506-5522.
Crossref
Crossref
Ornella Bosco, Barbara Vizio, Gabriella Gruden, Martina Schiavello, Bartolomeo Lorenzati, Paolo Cavallo-Perin, Isabella Russo, Giuseppe Montrucchio & Enrico Lupia. (2021) Thrombopoietin Contributes to Enhanced Platelet Activation in Patients with Type 1 Diabetes Mellitus. International Journal of Molecular Sciences 22:13, pages 7032.
Crossref
Crossref
John V. Forrester, Lucia Kuffova & Mirela Delibegovic. (2020) The Role of Inflammation in Diabetic Retinopathy. Frontiers in Immunology 11.
Crossref
Crossref
R. C. Sagar, K. M. Naseem & R. A. Ajjan. (2020) Antiplatelet therapies in diabetes. Diabetic Medicine 37:5, pages 726-734.
Crossref
Crossref
Habtamu B Beyene, Steven Hamley, Corey Giles, Kevin Huynh, Alexander Smith, Michelle Cinel, Natalie A Mellet, Maria G Morales-Scholz, Danielle Kloosterman, Kirsten F Howlett, Greg M Kowalski, Christopher S Shaw, Dianna J Magliano, Clinton R Bruce & Peter J Meikle. (2020) Mapping the Associations of the Plasma Lipidome With Insulin Resistance and Response to an Oral Glucose Tolerance Test. The Journal of Clinical Endocrinology & Metabolism 105:4, pages e1041-e1055.
Crossref
Crossref
Kabelo Mokgalaboni, Phiwayinkosi V Dludla, Tawanda M Nyambuya, Sinethemba H Yakobi, Vuyolwethu Mxinwa & Bongani B Nkambule. (2020) Monocyte-mediated inflammation and cardiovascular risk factors in type 2 diabetes mellitus: A systematic review and meta-analysis of pre-clinical and clinical studies. JRSM Cardiovascular Disease 9, pages 204800401990074.
Crossref
Crossref
Alessandra Vecchié, Fabrizio Montecucco, Federico Carbone, Franco Dallegri & Aldo Bonaventura. (2019) Diabetes and Vascular Disease: Is It All About Glycemia?. Current Pharmaceutical Design 25:29, pages 3112-3127.
Crossref
Crossref
Ercan Keskin & Deniz Uluışık. (2019) The Effect of Melatonin on Some Coagulation Parameters in Streptozotocin-induced Diabetic Rats. Kocatepe Veterinary Journal, pages 1-1.
Crossref
Crossref
. 2019. Diabetologie. Diabetologie
91
110
.
C. A. Cicchetto, C. R. C. Arruda, G. E. Meira, H. A. Ramos & T. A. de Macêdo. (2018) ASPIRINA NA PREVENÇÃO PRIMÁRIA DE EVENTOS CARDIOVASCULARES EM PACIENTES DIABÉTICOS: UMA REVISÃO. ASPIRINA NA PREVENÇÃO PRIMÁRIA DE EVENTOS CARDIOVASCULARES EM PACIENTES DIABÉTICOS: UMA REVISÃO.
Albino Carrizzo, Carmine Izzo, Marco Oliveti, Antonia Alfano, Nicola Virtuoso, Mario Capunzo, Paola Di Pietro, Mariaconsiglia Calabrese, Eros De Simone, Sebastiano Sciarretta, Giacomo Frati, Serena Migliarino, Antonio Damato, Mariateresa Ambrosio, Francesco De Caro & Carmine Vecchione. (2018) The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation. International Journal of Molecular Sciences 19:10, pages 2968.
Crossref
Crossref
M. Leggio, M.G. Bendini, E. Caldarone, M. Lombardi, P. Severi, S. D’Emidio, D.C. Stavri, M. Armeni, V. Bravi & A. Mazza. (2018) Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?. Diabetes & Metabolism 44:3, pages 217-225.
Crossref
Crossref
Hoda Ahmed Makhlouf, Samiaa Hamdy Sadek & Asmaa Abdel Hakim Nafady. (2018) Platelet function in diabetic and nondiabetic patients with chronic obstructive pulmonary disease: a case control study. The Clinical Respiratory Journal 12:1, pages 48-56.
Crossref
Crossref
Hafeez Ullah, Munir Akhtar & Fayyaz Hussain. 2018. Nanomaterials and Their Applications. Nanomaterials and Their Applications
289
314
.
Christina Cimenti, Axel Schlagenhauf, Bettina Leschnik, Elke Fröhlich-Reiterer, Hildegard Jasser-Nitsche, Harald Haidl, Elisabeth Suppan, Gudrun Weinhandl, Maximilian Leberl, Martin Borkenstein & Wolfgang E. Muntean. (2016) Only minor changes in thrombin generation of children and adolescents with type 1 diabetes mellitus – A case-control study. Thrombosis Research 148, pages 45-49.
Crossref
Crossref
Davide CapodannoDominick J. Angiolillo. (2016) Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus. Circulation 134:20, pages 1579-1594.
Crossref
Crossref
Gadi Shlomai, Tal Haran-Appel, Tal Sella, Yoni Grossman, Hagit Hauschner, Nurit Rosenberg & Ehud Grossman. (2015) High-risk type-2 diabetes mellitus patients, without prior ischemic events, have normal blood platelet functionality profiles: a cross-sectional study. Cardiovascular Diabetology 14:1.
Crossref
Crossref
O. V. Korkushko, E. V. Lugovskoy, V. B. Shatilo, I. N. Kolesnikova, V. A. Ischuk & S. S. Naskalova. (2016) Age features of the hemostatic system in people with insulin resistance and prediabetic carbohydrate metabolism disorders. Advances in Gerontology 5:4, pages 303-309.
Crossref
Crossref
Lusha Xiang, Peter N. Mittwede & John S. Clemmer. 2011. Comprehensive Physiology. Comprehensive Physiology
1815
1839
.
Athanasia Papazafiropoulou, Nikolaos Papanas, Stavros Pappas, Efstratios Maltezos & Dimitri P. Mikhailidis. (2015) Effects of oral hypoglycemic agents on platelet function. Journal of Diabetes and its Complications 29:6, pages 846-851.
Crossref
Crossref
Claudio Proscia, Annunziata Nusca, Mega Simona, Melfi Rosetta & Germano Di Sciascio. (2015) Platelet reactivity and antiplatelet management in diabetic patients with coronary artery disease. Interventional Cardiology 7:3, pages 283-293.
Crossref
Crossref
Anamika Singh, Guenther Boden & A. Koneti Rao. (2017) Tissue factor and Toll-like receptor (TLR)4 in hyperglycaemia-hyperinsulinaemia. Thrombosis and Haemostasis 113:04, pages 750-758.
Crossref
Crossref
A. Koneti Rao, Robert J. Freishtat, Gauthami Jalagadugula, Anamika Singh, Guangfen Mao, Andrew Wiles, Peter Cheung & Guenther Boden. (2014) Alterations in insulin-signaling and coagulation pathways in platelets during hyperglycemia-hyperinsulinemia in healthy non-diabetic subject. Thrombosis Research 134:3, pages 704-710.
Crossref
Crossref
Ying Wang, Li-ming Chen & Ming-lin Liu. (2014) Microvesicles and diabetic complications — novel mediators, potential biomarkers and therapeutic targets. Acta Pharmacologica Sinica 35:4, pages 433-443.
Crossref
Crossref
B. Łabuz-Roszak, K. Pierzchała & K. Tyrpień. (2014) Resistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smoking. Journal of Endocrinological Investigation 37:4, pages 331-338.
Crossref
Crossref
. 2014. Diabétologie. Diabétologie
71
88
.
Roberto R. Giraldez, Robert M. Clare, Renato D. Lopes, Anthony J. Dalby, Dorairaj Prabhakaran, Gerard X. BroganJr.Jr., Robert P. Giugliano, Stefan K. James, Jean-Francois Tanguay, Charles V. PollackJr.Jr., Robert A. Harrington, Eugene Braunwald & L. Kristin Newby. (2013) Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non–ST-segment elevation acute coronary syndrome. American Heart Journal 165:6, pages 918-925.e2.
Crossref
Crossref
Dorothee Kling, Corinne Stucki, Sven Kronenberg, Dietrich Tuerck, Eric Rhéaume, Jean-Claude Tardif, Jacques Gaudreault & Christophe Schmitt. (2013) Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab – preclinical and clinical studies. Thrombosis Research 131:5, pages 401-410.
Crossref
Crossref
David Vivas, Esther Bernardo, Julian Palacios-Rubio & Antonio Fernández-Ortiz. (2012) How to Manage Hyperglycemia in an Acute Coronary Syndrome Patient. Current Treatment Options in Cardiovascular Medicine 15:1, pages 93-103.
Crossref
Crossref
Kate F. McGovern, Kara M. Lascola, Stephanie A. Smith, Stuart C. Clark‐Price, Maureen McMichael & Pamela A. Wilkins. (2012) Assessment of acute moderate hyperglycemia on traditional and thromboelastometry coagulation parameters in healthy adult horses. Journal of Veterinary Emergency and Critical Care 22:5, pages 550-557.
Crossref
Crossref
Eunice Mah & Richard S. Bruno. (2012) Postprandial hyperglycemia on vascular endothelial function: mechanisms and consequences. Nutrition Research 32:10, pages 727-740.
Crossref
Crossref
C. D. Williams & M. S. Kirkman. (2011) Aspirin and Other Antiplatelet Agents and Their Effects on Cardiovascular Disease in Type 2 Diabetes. Current Cardiovascular Risk Reports 6:1, pages 62-70.
Crossref
Crossref
Eva Horová, Jiří Mazoch, Jiřina HiIgertová, Jan Kvasnička, Jan Škrha, Jan Šoupal & Martin Prázný. (2012) Acute Hyperglycemia Does Not Impair Microvascular Reactivity and Endothelial Function during Hyperinsulinemic Isoglycemic and Hyperglycemic Clamp in Type 1 Diabetic Patients. Experimental Diabetes Research 2012, pages 1-8.
Crossref
Crossref
K. L. Rensing, A. Q. Reuwer, B. J. Arsenault, J. H. von der Thüsen, J. B. L. Hoekstra, J. J. P. Kastelein & Th. B. Twickler. (2011) Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?. Diabetes, Obesity and Metabolism 13:12, pages 1073-1087.
Crossref
Crossref
Jennifer L. Gonzales, Rita M. Hanel, Bernie D. Hansen & Steve L. Marks. (2011) Effect of intravenous administration of dextrose on coagulation in healthy dogs. American Journal of Veterinary Research 72:4, pages 562-569.
Crossref
Crossref
Thomas Schöndorf, Petra B. Musholt, Cloth Hohberg, Thomas Forst, Ute Lehmann, Winfried Fuchs, Mirjam Löbig, Jürgen Müller & Andreas Pfützner. (2011) The Fixed Combination of Pioglitazone and Metformin Improves Biomarkers of Platelet Function and Chronic Inflammation in Type 2 Diabetes Patients: Results from the PIOfix Study. Journal of Diabetes Science and Technology 5:2, pages 426-432.
Crossref
Crossref
José Luis FerreiroDominick J. Angiolillo. (2011) Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome. Circulation 123:7, pages 798-813.
Crossref
Crossref
Nicholaos Kakouros, Jeffrey J. Rade, Antonios Kourliouros & Jon R. Resar. (2011) Platelet Function in Patients with Diabetes Mellitus: From a Theoretical to a Practical Perspective. International Journal of Endocrinology 2011, pages 1-14.
Crossref
Crossref
Olivier Morel, Laurence Kessler, Patrick Ohlmann & Pierre Bareiss. (2010) Diabetes and the platelet: Toward new therapeutic paradigms for diabetic atherothrombosis. Atherosclerosis 212:2, pages 367-376.
Crossref
Crossref
Ricki Y. Fram, Melanie G. Cree, Robert R. Wolfe, David Barr & David N. Herndon. (2010) Impaired Glucose Tolerance in Pediatric Burn Patients at Discharge From the Acute Hospital Stay. Journal of Burn Care & Research 31:5, pages 728-733.
Crossref
Crossref
Feng Gao, Tong Yan, Yan Zhao, Fan Yin & Cuining Hu. (2010) A possible mechanism linking hyperglycemia and reduced high-density lipoprotein cholesterol levels in diabetes. Journal of Huazhong University of Science and Technology [Medical Sciences] 30:3, pages 318-321.
Crossref
Crossref
Giampaolo Niccoli, Cristina Spaziani, Marcello Marino, Maria Luisa Pontecorvo, Nicola Cosentino, Marco Bacà, Italo Porto, Antonio Maria Leone & Filippo Crea. (2010) Effect of Chronic Aspirin Therapy on Angiographic Thrombotic Burden in Patients Admitted for a First ST-Elevation Myocardial Infarction. The American Journal of Cardiology 105:5, pages 587-591.
Crossref
Crossref
Vladimir Y. Bogdanov & Bjarne Østerud. (2010) Cardiovascular complications of diabetes mellitus: The Tissue Factor perspective. Thrombosis Research 125:2, pages 112-118.
Crossref
Crossref
Xinglong Cui, Akifumi Kushiyama, Masayasu Yoneda, Yusuke Nakatsu, Ying Guo, Jun Zhang, Haruya Ono, Machi Kanna, Hideyuki Sakoda, Hiraku Ono, Takako Kikuchi, Midori Fujishiro, Masashi Shiomi, Hideaki Kamata, Hiroki Kurihara, Masatoshi Kikuchi, Shoji Kawazu, Fusanori Nishimura & Tomoichiro Asano. (2010) Macrophage foam cell formation is augmented in serum from patients with diabetic angiopathy. Diabetes Research and Clinical Practice 87:1, pages 57-63.
Crossref
Crossref
. 2010. Diabétologie. Diabétologie
77
98
.
David J. Schneider. (2009) Factors Contributing to Increased Platelet Reactivity in People With Diabetes. Diabetes Care 32:4, pages 525-527.
Crossref
Crossref
Muthiah Vaduganathan, Carlos L. Alviar, Mehmet E. Arikan, Armando Tellez, Sadishar Guthikonda, Timothy DeLao, Juan F. Granada, Neal S. Kleiman, Christie M. Ballantyne & Eli I. Lev. (2008) Platelet reactivity and response to aspirin in subjects with the metabolic syndrome. American Heart Journal 156:5, pages 1002.e1-1002.e7.
Crossref
Crossref
Stacy R. Oliver, Rebecca L. Flores, Andria M. Pontello, Jaime S. RosaFrank P. Zaldivar & Pietro R. Galassetti. (2023) Acute Suppression of Circulating sCD40L during Hyperglycemia and Euglycemic-Hyperinsulinemia in Healthy Young Males. Journal of Investigative Medicine 56:7, pages 902-910.
Crossref
Crossref
Gilberto Inácio Lunkes, Daniéle Sausen Lunkes, Daniela Leal, Maria do Carmo Araújo, Maísa Corrêa, Lara Becker, Cintia Saydelles da Rosa, Vera Maria Morsch & Maria Rosa Chitolina Schetinger. (2008) Effect of high glucose levels in human platelet NTPDase and 5′-nucleotidase activities. Diabetes Research and Clinical Practice 81:3, pages 351-357.
Crossref
Crossref
Anetta Undas, Ilona Wiek, Ewa Stêpień, Krzysztof Zmudka & Wiesława Tracz. (2008) Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome. Diabetes Care 31:8, pages 1590-1595.
Crossref
Crossref
Camila Manrique, Guido Lastra, John Palmer, Michael Gardner & James R. Sowers. (2008) Review: Aspirin and Diabetes Mellitus: revisiting an old player. Therapeutic Advances in Cardiovascular Disease 2:1, pages 37-42.
Crossref
Crossref
Guenther Boden, Vijender R. Vaidyula, Carol Homko, Peter Cheung & A. Koneti Rao. (2007) Circulating Tissue Factor Procoagulant Activity and Thrombin Generation in Patients with Type 2 Diabetes: Effects of Insulin and Glucose. The Journal of Clinical Endocrinology & Metabolism 92:11, pages 4352-4358.
Crossref
Crossref
M. BorchertT. SchöndorfG. LübbenT. ForstA. Pfützner. (2007)
Review of the Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor
γ
Agonists on Platelet Function
. Diabetes Technology & Therapeutics 9:5, pages 410-420.
Crossref
Crossref
Guenther Boden & A. Koneti Rao. (2007) Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation. Current Diabetes Reports 7:3, pages 223-227.
Crossref
Crossref
Guenther Boden, Vijender Vaidyula, Carol Homko, Maria Mozzoli & A. Koneti Rao. (2007) Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein. American Journal of Physiology-Endocrinology and Metabolism 292:5, pages E1333-E1339.
Crossref
Crossref